Lyratherapeutics
1 known investors
Lyra Therapeutics is a clinical-stage biotechnology company developing drug-eluting nasal meshes for localized treatment of chronic rhinosinusitis. The company's lead candidate delivers anti-inflammatory medication directly to sinonasal tissues for patients with this inflammatory disease.
BiotechHealthtechMedical Devices